Why Is Stargardt Disease Often Misdiagnosed Early?

Stargardt disease is an inherited retinal disorder that usually affects both eyes and is characterized by a buildup of a fatty substance on the macula (the small center part of the retina responsible for sharp, detailed vision). In its early stages, the physical changes in the eye can be subtle or even absent during a routine clinical eye examination ^[1]. Because patients can experience symptoms like central vision loss, light sensitivity (photophobia), or color vision changes before physical damage is obvious to a doctor, these initial symptoms are sometimes attributed to other common conditions ^[2][1]. Early misdiagnoses may include amblyopia (lazy eye), a need for stronger glasses to correct a refractive error, or functional visual symptoms (sometimes called psychogenic vision loss) ^[1].

The Invisible Early Stages

When a doctor uses standard equipment to examine the fundus (the back of the eye), they are looking for characteristic physical signs of disease, such as yellowish flecks. However, these signs are not always present early on. For instance, in one study of patients with early ABCA4-related Stargardt disease, about 11% had no visible fundus abnormalities at their first consultation ^[1]. In that same study group, patients experienced an average diagnostic delay of three years ^[1]. Visual acuity can also fluctuate during the first few years, which can further obscure the fact that the vision loss is caused by a progressive retinal condition rather than normal variations or test anxiety ^[1].

Confusing Co-existing Conditions

Adding to the diagnostic challenge, common refractive errors often coexist with Stargardt disease. Research involving one specific cohort found that approximately 80% of Stargardt patients also had myopia (nearsightedness) ^[3]. When a young patient reports blurry vision, a doctor might naturally prescribe stronger glasses ^[3].

While glasses will correct the blur caused by the refractive error, they cannot correct vision loss caused by macular dysfunction. When new glasses fail to fully restore vision, doctors must broaden their clinical assessment. Until specialized tests are performed, functional visual symptoms might be considered a reasonable early possibility, as doctors must rule out both ocular and neurologic causes ^[1].

The Role of Specialized Testing

To accurately evaluate unexplained vision loss, doctors use specialized imaging and functional tests to gather more information that may reveal subtle retinal changes missed by a standard exam:

• Fundus Autofluorescence (FAF): This imaging technique can detect abnormal accumulations of lipofuscin (a byproduct of visual processing) in the retina before characteristic “flecks” appear on a regular exam ^[1][4].
• Optical Coherence Tomography (OCT): This technology takes cross-sectional images of the retina and can reveal early structural changes or thinning in the outer photoreceptor layers and retinal pigment epithelium, even when the surface appears normal ^[1][4].
• Functional Testing: Tests like visual field exams, color vision testing, or electroretinography (ERG) can help document the extent of the dysfunction ^[5][1].

Together, these tools help guide the differential diagnosis. If an inherited retinal disease is suspected, doctors may recommend genetic testing and genetic counseling to help clarify the diagnosis, though it is important to know that genetic results can sometimes be inconclusive ^[6].